Analytical Data
-
Gene name
CD157
- Application
-
Alternative Names
ADP-ribosyl cyclase; BST1; Cyclic ADP-ribose hydrolase 2; CD157
-
Species
Cynomolgus
-
Source
HEK293
-
Tag
C-8*His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
A0A2K5VGB5
-
Expression Region
G26-A289
-
Protein Length
Partial
-
Molecular Weight
40-50 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
CD157, also known as bone marrow stromal antigen 1 (BSA-1), is a type II membrane glycoprotein belonging to the NAD+-glycohydrolase enzyme family. It is primarily expressed on the surface of immune cells, particularly in activated monocytes and macrophages, and is involved in various biological processes, including leukocyte migration, inflammation, and immune response regulation. The role of CD157 in the immune system has garnered attention due to its implications in both protective immunity and pathological conditions such as autoimmune diseases and cancer. Research into CD157 recombinant proteins focuses on elucidating its functional properties, interactions with other molecules, and potential therapeutic applications. By producing CD157 in a recombinant form, scientists aim to study its enzymatic activity, which is known to facilitate the production of immunomodulatory molecules, and to explore its role in cell signaling pathways. Furthermore, understanding the three-dimensional structure of CD157 can provide insights into its ligand-binding capabilities and help identify novel inhibitors or agonists. Thus, CD157 recombinant proteins serve as a valuable tool in immune-related research and may pave the way for the development of targeted therapies for diseases involving dysregulated immune responses.
